Condition: High Grade Serous Ovarian Cancer · Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
The objective of this study is to explore the integration of in vivo and ex vivo of MRI with histology and molecular assessments to advance non-invasive characterization of tumor heterogeneity in high-grade serous ovarian cance
This description comes directly from the study's public registry record.
MOUSSION Aurore · 0467613102 · aurore.moussion@icm.unicancer.fr
Texier Emmanuelle · 0467613102 · emmanuelle.texier@icm.unicancer.fr
Always discuss trial participation with your own doctor first.
| NOUGARET Stephanie | Montpellier, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06084195